Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-08-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621003994 |
| _version_ | 1818848364861587456 |
|---|---|
| author | Nicholas A. Trum, BS Jasmine Zain, MD Chelsea Abad, NP Steven T. Rosen, MD Christiane Querfeld, MD, PhD |
| author_facet | Nicholas A. Trum, BS Jasmine Zain, MD Chelsea Abad, NP Steven T. Rosen, MD Christiane Querfeld, MD, PhD |
| author_sort | Nicholas A. Trum, BS |
| collection | DOAJ |
| first_indexed | 2024-12-19T06:16:10Z |
| format | Article |
| id | doaj.art-8c4832537b7a47c79bc5bb1dac9338eb |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-12-19T06:16:10Z |
| publishDate | 2021-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-8c4832537b7a47c79bc5bb1dac9338eb2022-12-21T20:32:51ZengElsevierJAAD Case Reports2352-51262021-08-01143742Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rashNicholas A. Trum, BS0Jasmine Zain, MD1Chelsea Abad, NP2Steven T. Rosen, MD3Christiane Querfeld, MD, PhD4Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, IsraelDepartment of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, CaliforniaDivision of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, CaliforniaDepartment of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, CaliforniaDivision of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Department of Pathology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, California; Correspondence to: Christiane Querfeld, MD, PhD, City of Hope and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA 91010.http://www.sciencedirect.com/science/article/pii/S2352512621003994adverse eventsbiologicscutaneous t-cell lymphomadrug reactiondupilumabmogamulizumab |
| spellingShingle | Nicholas A. Trum, BS Jasmine Zain, MD Chelsea Abad, NP Steven T. Rosen, MD Christiane Querfeld, MD, PhD Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash JAAD Case Reports adverse events biologics cutaneous t-cell lymphoma drug reaction dupilumab mogamulizumab |
| title | Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash |
| title_full | Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash |
| title_fullStr | Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash |
| title_full_unstemmed | Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash |
| title_short | Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash |
| title_sort | dupilumab as a therapy option for treatment refractory mogamulizumab associated rash |
| topic | adverse events biologics cutaneous t-cell lymphoma drug reaction dupilumab mogamulizumab |
| url | http://www.sciencedirect.com/science/article/pii/S2352512621003994 |
| work_keys_str_mv | AT nicholasatrumbs dupilumabasatherapyoptionfortreatmentrefractorymogamulizumabassociatedrash AT jasminezainmd dupilumabasatherapyoptionfortreatmentrefractorymogamulizumabassociatedrash AT chelseaabadnp dupilumabasatherapyoptionfortreatmentrefractorymogamulizumabassociatedrash AT steventrosenmd dupilumabasatherapyoptionfortreatmentrefractorymogamulizumabassociatedrash AT christianequerfeldmdphd dupilumabasatherapyoptionfortreatmentrefractorymogamulizumabassociatedrash |